What is Canton Strategic Holdings, Inc. Common Stock's market cap?

Canton Strategic Holdings, Inc. Common Stock (CNTN) has a market capitalization of $176.6M and trades on XNAS.

Who are Canton Strategic Holdings, Inc. Common Stock's competitors?

Canton Strategic Holdings, Inc. Common Stock's key competitors include MicroStrategy Incorporated, Marathon Digital Holdings, Inc., AbbVie Inc., and others. These companies compete in similar markets and product categories.

Who does Canton Strategic Holdings, Inc. Common Stock partner with?

Canton Strategic Holdings, Inc. Common Stock's notable partners include Canton Foundation, Intract Pharma Limited, Clear Street LLC, and others.

What subsidiaries does Canton Strategic Holdings, Inc. Common Stock have?

Canton Strategic Holdings, Inc. Common Stock's subsidiaries include Gravitas Life Sciences, Inc., HB Pharma Corp.

Where is Canton Strategic Holdings, Inc. Common Stock headquartered?

Canton Strategic Holdings, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2022.

CNT

Canton Strategic Holdings, Inc. Common Stock

CNTN

Canton Strategic Holdings is a dual-sector company that manages a digital asset treasury focused on the Canton Network while developing clinical-stage biopharmaceutical candidates.

Market cap

$176.61M-0.3%

Net income-$80.7M-547%

EPS (diluted)-$2.20+76.7%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 13, 2026

EPS-$0.17

Read the full report

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full

Operating income-$36.9M-1,348%

Net income-$47.3M-1,763%

EPS (diluted)-$0.23+76.8%

Balance sheet

See full

Cash & equivalents$41.5M+3,760%

Total equity$469.8M+57,767%

Total assets$584.7M+35,093%

Cash flow

See full

Operating cash flow-$7.6M-184%

Competitors

By market cap

AbbVie$441.54B+33.2%

MicroStrategy$33.6B-69.6%

Marathon Digital Holdings$5.0B-14.5%

MCG

Yorkville Acquisition Corp.$241.2M—

Verb Technology Company, Inc.$188.8M+1,773%

CNT

Canton Strategic Holdings, Inc. Common Stock$176.6M—

CYP

Cypherpunk Technologies Inc.$74.5M—

MEI Pharma$33.8M+93.5%

By revenue growth

Verb Technology Company, Inc.+663%

Marathon Digital Holdings+23.1%

AbbVie+9.5%

MicroStrategy+3.0%

By net margin

MicroStrategy1,663.11%-575pp

AbbVie5.79%-1.5pp

Marathon Digital Holdings-235.12%-188pp

Verb Technology Company, Inc.-1,416.59%-986pp

CYP

Cypherpunk Technologies Inc.-2,705.8%—

Profile

Canton Strategic Holdings is a dual-sector company that manages a digital asset treasury focused on the Canton Network while developing clinical-stage biopharmaceutical candidates. The company leverages its strategic reserve of Canton Coin to support institutional blockchain adoption and financial market digitization, while simultaneously advancing therapeutic programs for inflammatory and immunologic conditions.

Competitive position

The company is the first publicly traded entity to specifically leverage Canton Coin and participate in the governance of the Canton Network while maintaining a legacy clinical-stage biotech pipeline.

GeographiesUnited States, Global

Customer segmentsInstitutional investors, Healthcare providers, Government agencies

Business modelAsset management, Infrastructure-as-a-Service, Research and development

SuppliersInstitutional-grade digital asset custodians, Contract Manufacturing Organizations (CMOs), Canton Foundation, Academic research institutions

CustomersInstitutional blockchain users, Pharmaceutical commercialization partners, Military and emergency medical services

CountryUnited States of America

Listed2022

CEOMark Wendland

SectorPHARMACEUTICAL PREPARATIONS

IndustryPHARMACEUTICAL PREPARATIONS

FilingsSEC EDGAR

Questions, answered.

What is Canton Strategic Holdings, Inc. Common Stock's market cap?: Canton Strategic Holdings, Inc. Common Stock (CNTN) has a market capitalization of $176.6M and trades on XNAS.
Who are Canton Strategic Holdings, Inc. Common Stock's competitors?: Canton Strategic Holdings, Inc. Common Stock's key competitors include MicroStrategy Incorporated, Marathon Digital Holdings, Inc., AbbVie Inc., and others. These companies compete in similar markets and product categories.
Who does Canton Strategic Holdings, Inc. Common Stock partner with?: Canton Strategic Holdings, Inc. Common Stock's notable partners include Canton Foundation, Intract Pharma Limited, Clear Street LLC, and others.
What subsidiaries does Canton Strategic Holdings, Inc. Common Stock have?: Canton Strategic Holdings, Inc. Common Stock's subsidiaries include Gravitas Life Sciences, Inc., HB Pharma Corp.
Where is Canton Strategic Holdings, Inc. Common Stock headquartered?: Canton Strategic Holdings, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2022.